Skip to main content

Excessive Sleepiness

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Teva
TevaIsrael - Petach Tikva
2 programs
armodafinilPHASE_31 trial
ArmodafinilPHASE_41 trial
Active Trials
NCT00758498Completed427Est. Feb 2009
NCT01080807Completed385Est. Oct 2010
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
JZP-110PHASE_21 trial
Active Trials
NCT03037203Completed66Est. Aug 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TevaArmodafinil
Tevaarmodafinil
Jazz PharmaceuticalsJZP-110

Clinical Trials (3)

Total enrollment: 878 patients across 3 trials

NCT01080807TevaArmodafinil

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Start: Mar 2010Est. completion: Oct 2010385 patients
Phase 4Completed
NCT00758498Tevaarmodafinil

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

Start: Sep 2008Est. completion: Feb 2009427 patients
Phase 3Completed
NCT03037203Jazz PharmaceuticalsJZP-110

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Start: Jan 2017Est. completion: Aug 201866 patients
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.